Episode summary
WHOOP CEO, Will Ahmed: 50B Hours of Health Data, a 4 Million Member Data Moat, & the FDA Fight
All-In Podcast
· · 56 min · Hosts: Ben Horowitz, Chamath Palihapitiya, Jason Calacanis, David Sacks · Guests: Will Ahmed
Summary
Will Ahmed says WHOOP has grown into a 4 million-member subscription business built on unusually deep engagement rather than hardware sales. The company started as a $500 device, then pivoted to a lower monthly price because the real problem was acquisition, not retention; once members kept wearing it, WHOOP became a recurring-revenue product with stronger incentives to improve the software and the member experience.
Ahmed argues that WHOOP’s edge is its 50 billion hours of continuous physiological data, plus journals, labs, medical records, and an AI coach that can turn that data into personalized guidance. He describes the core product around sleep, recovery, strain, and health monitoring, and says the system has already helped detect issues ranging from infection signals to more serious conditions in members. He also says the journal and behavioral insights are crucial because they let WHOOP identify which habits improve or hurt recovery.
A major theme is WHOOP’s effort to broaden from performance wearables into health insights, including blood pressure, ECG, GLP-1 tracking, and bloodwork. Ahmed frames the FDA fight over blood pressure as a wellness-versus-medical boundary issue and says WHOOP ultimately helped push updated guidance. He also says the company does not sell user data and is focused on building its own models on top of the dataset.
Key takeaways
- Ahmed says WHOOP expects to reach 4 million members and has more than 50 billion hours of continuous physiological data.
- The subscription model replaced the $500 upfront hardware sale because the company had a sales problem, not a retention problem, Ahmed says.
- Ahmed says WHOOP’s journal and behavioral insights help link habits like alcohol, late meals, and warm baths to recovery outcomes.
- Ahmed says WHOOP is using its data to build AI models that may predict out-of-range biomarkers before they are directly measured.
- Ahmed says the FDA dispute over blood pressure was about whether the feature was wellness or medical, and that the rules later moved closer to WHOOP’s position.
Notable quotes
“On average, a Whoop member wears Whoop 23.6 hours a day. We have just over 50 billion hours of continuous physiological data”
“For a dollar a day, I think this is like one of the best things you could spend on your health”
“through physiological signals we might be able to predict that a biioarker is out of range without actually measuring the biioarker itself”
“we do not sell data. You know, you are not the product, Jason”
How the episode opens
On average, a Whoop member wears Whoop 23.6 hours a day. We have just over 50 billion hours of continuous physiological data. So, it's one of the largest health data sets in the world. — For a dollar a day, I think this is like one of the best things you could spend on your health.
You want people to love your product authentically. LeBron James is now a global ambassador for Whoop. He was one of the first 100 people to ever wear it. You're starting to understand things before the rest of the medical community is learning them.
Through physiological signals, we might be able to predict that a biomarker is out of range without actually measuring the biomarker itself. — As your wealth grows, have you noticed how much more complex things get between investments, tax strategy, and estate planning? Managing it all is a full-time job that you didn't ask for. Creative planning can help. Their coordinated team of investment managers, CPAs, and affiliated estate attorneys can do much of the heavy lifting so you don't have to. Creative planning, where wealth works together. Go to creativeplanning.com/allin.
All right, guys. Welcome back to the All-In interview program. Yeah, this is where guests we want to unpack for an hour or so.
Not talk about the news like we do every Friday. We want to go deep. And health and technology is one of those areas.
That's super interesting to all the besties and I was really excited that my friend Will I met uh from Whoop decided he would carve out an hour for me and the allin audience. You and I have spoken I think two or three times on the OG podcast this week in startups that I've been doing for over 15 years there in the journey for Whoop.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- health data
- subscription pivot
- ai coaching
- glp-1 tracking
- fda fight
Companies and tickers mentioned
- WHOOP
Watch the episode
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from All-In Podcast
-
Jensen OUT as Nvidia CEO: "Spy" Scandal, Export Restrictions, Market Impact -
Freedom vs. Safety: Axon CEO Rick Smith on the Future of Policing -
Midterm Blood Bath, $4T AI Sell Off, Data Center Freeze, What’s Next for Trump -
All-In Podcast REACTS to Democrat Sweep! -
Arvind Krishna & Nikesh Arora: Quantum Threat, Open vs Frontier AI, AI Cyber Warfare & SaaS Collapse -
Dylan Field: Is AI Replacing Designers?, Design is the New Code & Democratizing Creativity
All-In Podcast, this episode and its artwork belong to All-In Podcast, LLC. Octagon is not affiliated with the show; this page is an independent summary.
